Category Innovation/ R&D

Irrepressible Rise Of China In International Patent Applications, Developing Countries Lagging

If the United States remains the champion of international patent applications at the World Intellectual Property Organization, China is now on its heels, and knocked Japan off the second place in 2017, according to numbers provided by WIPO. Southeast Asia is now a strong source of international applications, while developing countries still stand as a poor relation of the intellectual property system, though some of them are progressing steadily.

UAEM Students Launch Campaign To Drop Publicly Funded Patent Claim On Cancer Drug In India

The Universities Allied for Essential Medicines (UAEM) this week launched a campaign to ask the University of California to drop its pursuit of a patent on the prostrate cancer drug Xtandi in India in order to make it affordable for patients. Xtandi sells at "exorbitant" rates in the United States, they said, a seeming violation of the licensing guidelines of the publicly funded University of California system which guarantees an "appropriate" return on taxpayer investments.

Sir John Sulston, Human Genome Project Leader, Remembered For Words On IP And Health R&D

Nobel Prize winner Sir John Sulston passed away on 6 March at the age of 75, and was widely remembered in the press and scientific circles, celebrating his research, his wisdom, and his leadership of the landmark Human Genome Project. Intellectual Property Watch recalls his visionary warning and advice a decade ago about the intellectual property system, investment, and science that is still valuable today.

Introduction Of A Grace Period In Europe

The protection of inventions is a cornerstone to encourage innovation as engine of economic growth. As one of the world‘s leading centres for innovation, the level of scientific and technological performance in Germany is very high, thanks to an excellent research landscape and a good technological and economic basis. But the global innovation competition is intensifying, and new competitors are seeking to enter international markets. However, Germany is falling short of its potential when it comes to leveraging technology to create new products, writes Michael Kahnert.

New IP-Sharing Framework To Accelerate R&D

Pharmaceutical R&D constantly leads to the generation of new intellectual property (IP), from clinical trial data to libraries of promising compounds. Not all IP assets generated by a company are used in their future R&D. When this happens, companies can choose instead to share them with other third-party researchers, under licensing agreements. The Access to Medicine Foundation has worked with BIO Ventures for Global Health (BVGH) to develop a framework for identifying which IP assets are most difficult for companies to share, yet most likely to speed up R&D of the medicines and vaccines needed by people living in low- and middle-income countries (LMICs), write Clarke B. Cole and Katie Graef.

EPO Reports Record Volume Of Patents, Seeks To Assure Quality

The European Patent Office today issued statistics which it claimed show the continued ascendance of Europe as a premier destination for patenting, not only from European countries. The statistics focus strongly on the increased volume of patents filed and granted, which it argued is a result of the office's focus on "efficiency and quality" and a boost to innovation.

Early Certainty Initiative Of The European Patent Office – Flexibility For Biotech Needed

In 2016, the European Patent Office (EPO) introduced a streamlined opposition procedure that should simplify opposition proceedings and deliver decisions faster, while giving parties more time to react to summons and prepare for oral proceedings. This new initiative, called early certainty, aimed to cut down the overall duration of granting new patents and to tackle the backlog in patent granting within the EPO, writes Michael Kahnert.

USPTO To Reveal New Design For Patents This Week

The United States Patent and Trademark Office (USPTO) will make public the new design for patents this week at the South by Southwest (SXSW) Interactive Festival in Austin, Texas. The new design will first be used on patent number 10 million, expected to issue this year. There have fewer than 12 basic design changes to the US patent since President George Washington granted the first patent in 1790, and only two in the last 100 years, USPTO said.

A Look At The Role Of Governments, Universities, Science In Health Innovation & Access

Intellectual property rights, particularly patents, are considered by some as being a barrier in access to medicines despite being a stimulus for innovation. At a recent symposium co-organised by the World Health Organization, World Trade Organization and World Intellectual Property Organization, speakers also talked about the role of science, governments, and universities in health innovation and access, and how to address challenges such as secondary patents.

Protecting And Promoting Copyright Balance In NAFTA

The ongoing NAFTA renegotiation presents a prime opportunity to move the ball on protecting and promoting general public interest copyright exceptions. All three countries have such exceptions to varying degree. And all three are under threat from an agenda to cabin their use through international law. NAFTA negotiators can and should include the best models from prior international agreements that protect and promote the ability of countries to have general exceptions, writes Professor Sean Flynn.